Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019

benzinga.com/general/health-care/25/05/45677512/alcon-secures-first-fda-approval-since-novartis-spin-off-in-2019

The U.S. Food and Drug Administration (FDA) on Wednesday approved Alcon Plc’s (NYSE:ALC) Tryptyr (acoltremon ophthalmic solution) 0.003%, formerly known as AR-15512, for signs and symptoms of Dry Eye Disease (DED).
Alcon produces contact lenses, dry eye drops, gels and other related…

This story appeared on benzinga.com, 2025-05-29 17:28:03.
The Entire Business World on a Single Page. Free to Use →